Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Adalat Inhibits Carotid Artery Thickening: INSIGHT Side-arm Study
July 2, 2001
- Kirin, Corixa to Jointly Develop Antibody Drugs by Using TC Mouse
July 2, 2001
- BUSINESS NEWS IN BRIEF -2-
July 2, 2001
- 2001 Novartis Foundation Grant for Gerontological Research Goes to 5 People
July 2, 2001
- BUSINESS NEWS IN BRIEF -1-
July 2, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 2, 2001
- China, Taiwan Added to Servier's Territory for Kissei's Mitiglinide
July 2, 2001
- Fresenius Medical Care to Become Major Player in Japan: President van Hest
July 2, 2001
- Physicians Should Also Be Forbidden to Receive Gifts: Maker FTC
July 2, 2001
- REGULATORY NEWS IN BRIEF
July 2, 2001
- Bayer AG to Increase Share in Asia-Pacific from 16% to 25%
July 2, 2001
- Japan Is Lagging Behind the US in Life Science: S&T White Paper
July 2, 2001
- M&A, Alliance Effective for Strengthening R&D Ability: EAD Director
July 2, 2001
- CORPORATE ROUNDUP
July 2, 2001
- Aventis Aiming to Achieve Highest Growth Rate in Japan: President Loescher
July 2, 2001
- Council for Regulatory Reform to Focus on Medical Fees, NHI Prices
July 2, 2001
- Blopress, Nu-lotan Up Remarkably, But Mevalotin, Lipovas Down: Top 100 Products
July 2, 2001
- 48 New Active Ingredients Approved in FY2000
July 2, 2001
- Otsuka to Acquire Meretek of the US
July 2, 2001
- Takeda's Ixense for ED Launched in France, Germany
July 2, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…